Intro to Breast Cancer Flashcards
How do the breast change during life?
- Pre-pregnancy
- Pregnancy
- Post-menopausal
- Pre-pregnancy
- Neonatal
- Pubertal
- Menstrual cycle
- Pregnancy
- Lactational change
- Postmenopausal
- Atrophy

What can be done to diagnose a breast lesion?
- Self examination
-
Imaging
- Mammography
- Ultrasound
- MRI
-
Biopsy
- Fine needle aspiration
- Core needle biopsy
- Vacuum assisted or mammotome
- Excisional
Screening vs. Diagnostic Mammograms (differences?):
-
Screening occurs in asymptomatic women
- 40-50 years: every year or every other year
- >50 years: yearly screening
- 1st degree relative with breast cancer: screening begins 10 years before the age at diagnosis in the 1st degree relative
- Diagnostic mammograms are used to evaluate a palpable lesion
What are suspicious mammographic findings?
- Density
- These carcinomas are ½ the size of palpable ones
- Microcalcifications
- Picks up even smaller lesions
- May herald an in situ carcinoma
- Magnification or compression views may aid in the evaluation of mammographic abnormalities
When is an ultrasound used to evaluate breast tissue?
- Often used in women younger than 35 years especially if the lesion is clinically benign
- Can differentiate solid from cystic masses
- Often used in conjunction with mammography
What are the indications for a breast MRI?
- Pre-operative evaluation of extent of malignant disease/contralateralprocess
- Evaluate tumor response to neo-adjuvant chemotherapy
- Axillarylymph node positive for metastatic carcinoma with unknown primary
- Evaluate integrity silicone breast implant
- High risk screening
What are different types of breast pathology specimens?
- FNA
- Core biopsy
- Excisional biopsy
- Excision / lumpectomy
- Mastectomy
- Lymph nodes:
- sentinel node
- axillary dissection

What are the advantages/disadvantages of a fine needle aspirate (FNA)?
- Safe, accurate and well tolerated
- Requires subspecialty expertise for interpretation
- Cannot distinguish between in situ and invasive lesions
- Higher rate of false negative results
How is a core needle biopsy obtained?
- 8, 11 or 14 gauge needles
- Several cores are usually obtained
- False negatives are usually due to sampling error
- Can be obtained using radiologic guidance if the mass is small, deep, mobile, vaguely palpable or multiple
- What is a lumpectomy?
- What is used for orientation?
- Needle localization biopsy
- Oriented with clips
- What is the “triple test”?
- How is it interpreted?
- Combination of physical examination, imaging studies and biopsy
-
If all three tests point to a benign diagnosis,
- it is likely that the process is benign
- can be followed without requiring surgical removal (95% sensitive)
-
If there is any discordance among the three tests,
- further studies are indicated
Most common lesion best on age group:
- **15-25: **
- **25-35: **
- **35-50: **
- **Over 50: **
- Pregnant or lactating:
-
15-25
- Fibroadenoma
-
25-35
- Fibroadenoma (cyst or cancer possible but uncommon)
-
35-50
- Fibrocystic changes, cancer, cyst
-
Over 50
- Cancer until proved otherwise
-
Pregnant or Lactating
- Lactating adenoma, cyst, mastitis, cancer
What are the inflammatory conditions of the breast?
- Acute mastitis
- Periductal mastitis
- Mammary duct ectasia
- Fat necrosis
- Other (lymphocytic mastopathy, granulomatous mastitis, plasma cell mastitis, galactocele)
What are the benign** epithelial lesions** of the breast?
- Non-proliferative breast changes (fibrocystic changes)
- Proliferative breast disease without atypia
- Proliferative breast disease with atypia
What are the different types of non-proliferative breast changes (Fibrocystic Changes)?
- Cysts
- Fibrosis
- Apocrine metaplasia
Non-proliferative Breast Changes (Fibrocystic Changes):
Clinical Presentation
- May present as lumpy breast, mass, calcifications, nipple discharge
- Pain, tenderness, pain may occur in the premenstrual phase of the cycle
- Masses may be multiple and/or bilateral and may fluctuate in size
Non-proliferative Breast Changes (Fibrocystic Changes)
- Age predilection
- Incidence
- Age predilection
- Premenopausal (30 –50 years old)
- Incidence
- May be part of normal spectrum
- Most common benign condition of the breast
Proliferative Breast Disease Without Atypia:
Clinical Findings
- Mammographic densities (rarely form masses)
- Calcifications
- Incidental
Different Types of Proliferative Breast Disease Without Atypia
Includes:
- Moderate, florid hyperplasia
- Sclerosingadenosis
- Complex sclerosing lesions
- Papillomas
What is ductal hyperplasia?
- Lumen filled by heterogeneous population of cells
- Different morphologies –myoepithelial and epithelial
- Irregular slit-like fenestrations, prominent at periphery

Describe sclerosing adenosis:
- Enlarged lobule, circumscribed edge
- Preserved background lobular architecture
- Compressed and distorted acini
- Dense stroma, calcifications

What is the clinical presentation of complex sclerosing adenosis?
- Most common between 40 and 60 years of age
- Rarely palpable
- Usually detected by mammography
- Mammogram shows a stellate or spiculated lesion with a central core
- Biopsy is needed for confirmation of diagnosis
- Complete excision is warranted
How does a complex sclerosing adenosis (radial scar) appear microscopically?
- Stellate lesion
- Central hyalinized stroma with entrapped glands
- Dilated ducts at periphery

What is the clinical presentation of papilloma?
- May occur at any age
- Majority are located in the central breast
-
Nipple discharge is the primary symptom in up to 80% of cases (less common in peripheral lesions)
- Bloody discharge occurs in 71% of central papillomas
- Subareolar mass may be present
How does a papilloma appear microscopically?
- Branching fibrovascular cores within duct
- Epithelial hyperplasia often present

List the types of Proliferative Breast Disease With Atypia (2):
- Atypical ductal hyperplasia
- Atypical lobular hyperplasia
What is the microscopic appearence of atypical hyperplasia?
- Resembles in situ carcinoma
- Lacks quantitative or qualitative features for this diagnosis

Relative risk for invansive carcinoma for the following group:
- Adenosis
- Fibroadenoma
- Fibrosis
- Hyperplasia without atypia
- Cysts
- Apocrine metaplasia
no increased risk
Relative risk for invansive carcinoma for the following group:
- Complex fibroadenoma
- Florid hyperplasia without atypia
- Sclerosing adenosis
- Solitary papilloma
Slightly increased risk (1.5 - 2.0)
Relative risk for invansive carcinoma for the following group:
- Atypical ductal hyperplasia
- Atypical lobular hyperplasia
Moderately increased risk (4.0 - 5.0)
Relative risk for invansive carcinoma for the following group:
- DCIS (ipsilateral breast)
- LCIS (both breasts)
Significantly increased risk (8.0-10.0)
List the stromal breast tumors:
- Fibroadenoma
- Phyllodes tumor
- Sarcomas
What is the most common breast tumor in young adults?
Fibroadenoma
Fibroadenoma
- Peak incidence:
- Clinical Presentation:
- Regression?

- Peak incidence: 3rd decade
- Less than 5% postmenopausal
- Solitary, well-circumscribed, movable, painless nodule
- Multiple - 15%
- Regression during menopause

Phyllodes Tumor:
- Gross appearance:
- Peak Incidence:
- Palpable?
- Aggressive?

-
Large, fibroepithelial tumor
- Benign or malignant
- Most in 5th, 6th decade
- < 1% of breast tumors
- Latin women 3 -4x increased incidence
- Discrete palpable breast mass
- Rapid growth
Phyllodes Tumor:
Benign features
- Circumscribed
- Not encapsulated
- Gray-tan cut surface
- Interlacing clefts
- Cysts
- Necrosis
- Hemorrhage

What are microscopic findings of a benign phyllodes tumor?
- Leaf-like or epithelium lined clefts, cysts
- Increase in stromal cellularity
- Stromal overgrowth
What are the malignant features of a phyllodes tumor?
- Marked stromal cellularity
- Increased mitoses
- Low grade: 2-5 per 10 hpf
- High grade: >5 per 10 hpf
- Cellular pleomorphism
- Infiltrating border
- Necrosis
**Prognosis of Phyllodes Tumor: **
- Benign:
- Low grade:
- High grade:
-
Benign phyllodes tumor
- May recur
-
Low grade phyllodes tumor
- May recur, rarely metastasize
-
High grade phyllodes tumors
- Aggressive
- Distant mets in 1/3 cases
- Axillary node metastases